These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29665102)

  • 1. Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant.
    Bajaj JS; Kakiyama G; Savidge T; Takei H; Kassam ZA; Fagan A; Gavis EA; Pandak WM; Nittono H; Hylemon PB; Boonma P; Haag A; Heuman DM; Fuchs M; John B; Sikaroodi M; Gillevet PM
    Hepatology; 2018 Oct; 68(4):1549-1558. PubMed ID: 29665102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials.
    Bajaj JS; Shamsaddini A; Fagan A; Sterling RK; Gavis E; Khoruts A; Fuchs M; Lee H; Sikaroodi M; Gillevet PM
    Hepatol Commun; 2021 Feb; 5(2):258-271. PubMed ID: 33553973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis.
    Bajaj JS; Salzman N; Acharya C; Takei H; Kakiyama G; Fagan A; White MB; Gavis EA; Holtz ML; Hayward M; Nittono H; Hylemon PB; Cox IJ; Williams R; Taylor-Robinson SD; Sterling RK; Matherly SC; Fuchs M; Lee H; Puri P; Stravitz RT; Sanyal AJ; Ajayi L; Le Guennec A; Atkinson RA; Siddiqui MS; Luketic V; Pandak WM; Sikaroodi M; Gillevet PM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31751317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.
    Bajaj JS; Salzman NH; Acharya C; Sterling RK; White MB; Gavis EA; Fagan A; Hayward M; Holtz ML; Matherly S; Lee H; Osman M; Siddiqui MS; Fuchs M; Puri P; Sikaroodi M; Gillevet PM
    Hepatology; 2019 Nov; 70(5):1690-1703. PubMed ID: 31038755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder.
    Bajaj JS; Gavis EA; Fagan A; Wade JB; Thacker LR; Fuchs M; Patel S; Davis B; Meador J; Puri P; Sikaroodi M; Gillevet PM
    Hepatology; 2021 May; 73(5):1688-1700. PubMed ID: 32750174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.
    Bajaj JS; Kassam Z; Fagan A; Gavis EA; Liu E; Cox IJ; Kheradman R; Heuman D; Wang J; Gurry T; Williams R; Sikaroodi M; Fuchs M; Alm E; John B; Thacker LR; Riva A; Smith M; Taylor-Robinson SD; Gillevet PM
    Hepatology; 2017 Dec; 66(6):1727-1738. PubMed ID: 28586116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant.
    Liu R; Kang JD; Sartor RB; Sikaroodi M; Fagan A; Gavis EA; Zhou H; Hylemon PB; Herzog JW; Li X; Lippman RH; Gonzalez-Maeso J; Wade JB; Ghosh S; Gurley E; Gillevet PM; Bajaj JS
    Hepatology; 2020 Feb; 71(2):611-626. PubMed ID: 31220352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D.
    Singh P; Alm EJ; Kelley JM; Cheng V; Smith M; Kassam Z; Nee J; Iturrino J; Lembo A
    Gut Microbes; 2022; 14(1):2020067. PubMed ID: 35014601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment.
    Hassouneh R; Bajaj JS
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteral broad-spectrum antibiotics antagonize the effect of fecal microbiota transplantation in preterm pigs.
    Brunse A; Offersen SM; Mosegaard JJ; Deng L; Damborg P; Nielsen DS; Sangild PT; Thymann T; Nguyen DN
    Gut Microbes; 2021; 13(1):1-16. PubMed ID: 33382952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis.
    Bajaj JS; Shamsaddini A; Acharya C; Fagan A; Sikaroodi M; Gavis E; McGeorge S; Khoruts A; Fuchs M; Sterling RK; Lee H; Gillevet PM
    Gut Microbes; 2021; 13(1):1993584. PubMed ID: 34743650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis.
    Shamsaddini A; Gillevet PM; Acharya C; Fagan A; Gavis E; Sikaroodi M; McGeorge S; Khoruts A; Albhaisi S; Fuchs M; Sterling RK; Bajaj JS
    Gastroenterology; 2021 Aug; 161(2):508-521.e7. PubMed ID: 33857456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
    Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
    Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.
    Kakiyama G; Pandak WM; Gillevet PM; Hylemon PB; Heuman DM; Daita K; Takei H; Muto A; Nittono H; Ridlon JM; White MB; Noble NA; Monteith P; Fuchs M; Thacker LR; Sikaroodi M; Bajaj JS
    J Hepatol; 2013 May; 58(5):949-55. PubMed ID: 23333527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT)
    Garza-González E; Mendoza-Olazarán S; Morfin-Otero R; Ramírez-Fontes A; Rodríguez-Zulueta P; Flores-Treviño S; Bocanegra-Ibarias P; Maldonado-Garza H; Camacho-Ortiz A
    Can J Gastroenterol Hepatol; 2019; 2019():4549298. PubMed ID: 31976311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy.
    Saboo K; Shamsaddini A; Iyer MV; Hu C; Fagan A; Gavis EA; White MB; Fuchs M; Heuman DM; Sikaroodi M; Iyer RK; Gillevet PM; Bajaj JS
    J Hepatol; 2021 Jan; 74(1):80-88. PubMed ID: 32679299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora.
    Wei Y; Gong J; Zhu W; Tian H; Ding C; Gu L; Li N; Li J
    BMC Microbiol; 2016 Nov; 16(1):255. PubMed ID: 27809778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiome therapeutics for hepatic encephalopathy.
    Bloom PP; Tapper EB; Young VB; Lok AS
    J Hepatol; 2021 Dec; 75(6):1452-1464. PubMed ID: 34453966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent
    Wei S; Bahl MI; Baunwall SMD; Dahlerup JF; Hvas CL; Licht TR
    Gut Microbes; 2022; 14(1):2084306. PubMed ID: 36519447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.